To determine whether participation in usual moderate-intensity or more-vigorous physical activity (MVPA) is associated with physical function performance and to identify sociodemographic, psychosocial, and diseaserelated covariates that may also compromise physical function performance. DESIGN: Cross-sectional analysis of baseline variables of a randomized controlled intervention trial. SETTING: Four academic research centers. PARTICIPANTS: Four hundred twenty-four older adults aged 70 to 89 at risk for mobility disability (scoring o10 on the Short Physical Performance Battery (SPPB)) and able to complete the 400-m walk test within 15 minutes. MEASUREMENTS: Minutes of MVPA (dichotomized according to above or below 150 min/wk of MVPA) assessed according to the Community Healthy Activities Model Program for Seniors questionnaire, SPPB score, 400-m walk test, sex, body mass index (BMI), depressive symptoms, age, and number of medications. RESULTS: The SPPB summary score was associated with minutes of MVPA (r 5 0.16, P 5.001). In multiple regression analyses, age, minutes of MVPA, number of medications, and depressive symptoms were associated with performance on the composite SPPB (Po.05). There was an association between 400-m walk time and minutes of MVPA (r 5 À 0.18; Po.001). In multiple regression analyses, age, sex, minutes of MVPA, BMI, and number of medications were associated with performance on the 400-m walk test (Po.05). CONCLUSION: Minutes of MVPA, sex, BMI, depressive symptoms, age, and number of medications are associated with physical function performance and should all be taken into consideration in the prevention of mobility disability.
1
There is indication that routine PA may be a determinant of physical function performance in older adults. Crosssectional studies report better summary performance scores in older adults with and without peripheral arterial disease (PAD) who engage in higher levels of routine PA. 2 There is further indication that moderate-intensity structured exercise may be more relevant to maintaining or improving physical function performance than other levels of activity, as demonstrated in cross-sectional, 3 observational, 4 and intervention 5 studies. These studies report that moderateintensity structured exercise imparts greater benefits on physical function performance than inactivity, activity performed throughout the day, 3 short-term PA, 4 and healthrelated education on successful aging. 5 The data are robust for moderate-intensity structured exercise, but whether this has been observed with moderate-intensity routine PA remains elusive. Because the risk of injury with aging and problems associated with adherence, more-vigorous forms of PA are recommended for more-experienced older adults. 1 Sex, adiposity, depressive symptoms, age, and concomitant medications may also compromise physical function in older adults. It has been reported that gardening activity was associated with performance on the 3-m walk and chair-rise tests in women but not men. 6 A recent study suggested that body mass index (BMI) influences functional performance in older adults such that obese older adults perform worse on the Short Performance Physical Battery (SPPB) than their nonobese counterparts. 7 Individuals with depressive symptoms show greater decline in 6-minute walk distance, fast walking velocity, and SPPB summary score than those with no depressive symptoms. 8 Nonagenarians perform worse on the Reduced Continuous Scale-Physical Function Performance Test than adults aged 60 to 74, an effect that is correlated with lower levels of PA. 9 Finally, polypharmacy is common in older adults and, depending on the drug class, may be related to physical function decline. 10 The purpose of this report was to determine whether minutes of usual moderate-intensity or more-vigorous PA (MVPA), sex, BMI, depressive symptoms, age, and number of medications would be associated with performance on the SPPB and 400-m walk test, two commonly used measurements of physical functioning. 11, 12 Data from the Lifestyle Interventions for Elders Pilot (LIFE-P), a multicenter, randomized controlled trial conducted in older adults at risk for mobility disability, were used. 13 
METHODS

Overview of Study Design
The LIFE-P was a multicenter pilot study comparing the efficacy of PA with that of a successful aging (SA) educational intervention on the incidence of major mobility disability or death in at-risk older adults. A full description of the LIFE-P study design has been reported elsewhere. 13 Briefly, participants were randomized into a PA program that combined aerobic, strength, balance, and flexibility exercises or a SA program that consisted of non-PAoriented educational information concerning healthy aging. Assessments of interest for the current investigation, physical functioning, and physical activity were conducted within 1 month of each other. Participants were followed for 12 to 18 months, depending on the month of randomization.
Participant Eligibility and Recruitment
Determinants of eligibility have been described previously. 13 Briefly, 424 participants were recruited through public advertisements and related community strategies from the Cooper Institute, Dallas, Texas; Stanford University, Palo Alto, California; University of Pittsburgh, Pittsburgh, Pennsylvania; and Wake Forest University, Winston-Salem, North Carolina. 13 Eligibility criteria were 13 aged 70 to 89, a score less than 10 on the SPPB, 11 ability to walk 400 m unassisted within 15 minutes, and a sedentary lifestyle reported during the initial several-item screening instrument (i.e., o20 min/wk of regular PA in the preceding month). Participants were excluded if they had a diagnosed psychiatric or cognitive disorder or a severe chronic disease for which moderate-intensity PA would be contraindicated (e.g., New York Heart Association Class III or IV congestive heart failure). Temporary exclusions were given to participants who had undergone surgery in the previous 6 months or had any condition that could be treated medically (uncontrolled hypertension: systolic blood pressure 4200 mmHg or diastolic blood pressure 4110 mmHg). Participants were also temporarily excluded if they were participating in another randomized trial involving an intervention. All participants gave informed consent, and the institutional review boards of all participating sites approved the study.
Assessment of Physical Function
The SPPB summary score and 400-m walk time were used to determine level of physical functioning. 11, 12 The SPPB summary score is predictive of future mobility disability risk [14] [15] [16] and mortality; 11 400-m walk time is also predictive of mobility disability risk 15 and mortality. 12 Participants were included in the study if their baseline SPPB summary score was less than 10. The SPPB comprises a timed standing balance assessment, a gait speed assessment, and timed chair stands. 11 The standing balance assessment is performed by asking the participant to maintain the feet in side-by-side, semi-tandem, and tandem positions for 10 seconds. The gait assessment is a 4-m self-paced walk at usual speed. Participants are given two attempts, and the better of the two is used. The last component of the SPPB, the chair rise assessment, requires participants to rise from a chair and sit down five times without using the arms as quickly as possible. Performance on each of the three elements is scored between 0 and 4, with a summary score computed for the three elements ranging from 0 to 12. Summary scores approaching 12 reflect a higher level of physical functioning.
The 400-m walk, as administered in the LIFE-P, was a timed self-paced walk that must be performed unassisted and without the use of a walking device. Participants were required to complete 400 m in less than 15 minutes.
Determination of PA Status
Baseline participation in PA was measured using the Community Healthy Activities Model Program for Seniors (CHAMPS) PA questionnaire. 17 Preintervention participation in PA was quantified as greater and less than 150 min/ wk of MVPA (activities using !3.0 metabolic equivalents, e.g., walking, cycling, swimming, gardening and golf). 17 Although a sedentary lifestyle, assessed through a brief screening interview, was an eligibility criterion in the LIFE-P, there was a subset of individuals who subsequently reported engaging in MVPA at baseline when the CHAMPS PA questionnaire, a more-quantitative self-report measure of PA that allowed for more accurate PA recall, was administered. 17 This self-report questionnaire assesses frequency and duration of moderate-intensity and all PA from the preceding 4 weeks and is sensitive particularly to moderate-intensity PA. 18 The original goal of the LIFE-P was to increase moderate-intensity PA by walking at least 150 min/ wk, 13 so preintervention participation in PA was quantified as greater and less than 150 min/wk of MVPA, 17 and participants were dichotomized accordingly into these groups.
Baseline Assessment of BMI, Number of Medications, and Depressive Symptoms Measured BMI was calculated at baseline weight (kg)/ height (m 2 ). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale. 19 Participants were also requested to bring prescription and nonprescription medications they had taken in the preceding 2 weeks to the baseline visit. These were documented in their charts. Other variables of interest were age and sex.
Statistical Analyses
Analyses for the current investigation were conducted on baseline data only. Pearson correlation coefficients were used to determine whether the SPPB summary score and scores from performance elements that comprise the SPPB (balance, chair stand, and walk speed) and 400-m walk time were associated with minutes of MVPA. Using data from the CHAMPS, Student t-tests were conducted to test whether SPPB summary scores, elements of the SPPB, and 400-m gait time were different in participants reporting 150 min/wk or more of MVPA and those reporting less than 150 min min/wk. Backward stepwise regression elimination models were used to identify variables in a final composite model predicting baseline SPPB score and 400-m walk time using MVPA and other covariates. Given their known associations with PA level, other covariates that were considered were age, sex, BMI, number of medications, and depressive symptoms. Covariates were forced into a model along with MVPA and retained in the composite model if they had a P-value o.05. Results are reported as means AE standard deviations unless otherwise noted. Table 1 . Participants were separated into two groups according to greater (n 5 98) and less (n 5 319) than 150 min/wk of MVPA. In general, there was a larger percentage of women in the lower group (P 5.04). Participants reporting 150 min/wk or more had more depressive symptoms than their less-active peers (P 5.01). There were no differences between the groups in age, BMI, or number of medications.
RESULTS
Baseline characteristics of participants are presented in
Association Between SPPB and Minutes of MVPA SPPB summary scores were associated with minutes of MVPA (r 5 0.16, P 5.001). Mean SPPB score for participants reporting 150 min/wk or more of MVPA was significantly higher (8.0 AE 1.2) than for those reporting less than 150 min/wk (7.4 AE 1.5; Po.001).
Performance was better for each of the individual components measured in the participants reporting 150 min/wk or more of moderate-intensity PA, but none of these associations were statistically significant.
Multiple regression analyses were performed to determine associations with SPPB summary score using age, sex, minutes of MVPA, BMI, number of medications, and depressive symptoms as independent variables. Age, minutes of MVPA, number of medications, and depressive symptoms were significant at the Po.05 level and constituted the final composite model of correlates of the SPPB summary score ( Table 2 ). The coefficients of determination (R 2 ) for the full and final composite models were 0.09 and 0.10, respectively.
Association Between 400-m Walk Time and Minutes of MVPA There was a significant association between 400-m walk time and minutes of MVPA (r 5 À 0.18; Po.001). Mean 400-m walk time for the group performing less than 150 min/wk of MVPA was significantly higher (8.4 AE 2.1 minutes) than for those performing 150 min/wk or more (7.5 AE 1.6 minutes; Po.001).
Multiple regression analyses were performed to identify correlates of 400-m walk time using age, sex, minutes of MVPA, BMI, number of medications, and depressive symptoms as potential correlates. Age, sex, minutes of MVPA, BMI, and number of medications were significant at the Po.05 level and constituted the final composite model as correlates of 400-m walk time ( Table 3 ). The R 2 for the full and final composite models were 0.17 and 0.16, respectively.
DISCUSSION
The purpose of the current investigation was to evaluate the baseline associations between MVPA and performance on the SPPB and 400-m walk test in a sample of adults aged 70 to 89 at risk for mobility disability. The data indicate that MVPA was associated with performance on the SPPB and 400-m walk test. Participants engaging in 150 min/wk or more of MVPA, as measured according to the CHAMPS questionnaire, performed significantly better on the SPPB and 400-m walk test than those engaging in less than 150 min/wk of MVPA. These associations remained after controlling for variables that have been found to be related to physical function.
To the authors' knowledge, this study is unique in its examination of the specific relationship between MVPA and performance on the SPPB. Although information on PA intensity typically has not been available, other studies of interest have reported a positive association between PA in general and performance on the SPPB. 2, 3 In a crosssectional report, better summary performance scores were associated with higher levels of accelerometer-measured PA in older adults with and without PAD. 2 Physical activity intensity was not assessed in this study, but the reported activity count is consistent with low-intensity PA as determined through similar accelerometer devices. 20 In two more-recent studies, investigators reported complementary results in this population and extended their findings to other functional outcomes such as 6-minute walk distance and 4-m walk time. 21, 22 Other cross-sectional data, from the Health, Aging and Body Composition (Health ABC) Study, support an association between lifestyle PA (defined as older adults who were physically active daily but did not participate in structured exercise) and functional performance. 3 Investigators designated participants as inactive, lifestyle active, and exercisers. Inactive participants engaged in less than 1,000 kcal/wk of exercise activity and 2,719 kcal/wk or less of total PA, lifestyle-active participants engaged in less than 1,000 kcal/wk of exercise activity and more than 2,719 kcal/wk of total PA, and exercisers engaged in 1,000 kcal/wk or more of exercise activity.
Information on PA intensity was gathered through selfreport. Lifestyle-active participants engaged in lightintensity PA (e.g., walking for exercise and aerobic dance) and exercisers in MVPA (e.g., jogging and swimming). Exercisers had better summary performance scores than inactive older adults. After controlling for disease and demographic variables, there was no difference in summary performance scores between lifestyle-active adults and exercisers, providing further support for the importance of MVPA in physical function performance.
A significant association was not observed between minutes of MVPA and the individual elements that constitute the SPPB, but the associations were all in the expected direction. In contrast, other cross-sectional and longitudinal observations have found that routine forms of PA, of estimated light intensity, were associated with the Ã Anxiety, fatigue, decreased appetite, insomnia, dizziness, muscle or joint stiffness, muscle strain or soreness, ankle or knee sprain, and foot pain. ÃÃ P-values not shown because participants were dichotomized according to these variables.
SD 5 standard deviation.
individual components that constitute the SPPB.
2,21,22
Quantification of PA obtained from these investigations was directly assessed using accelerometry, in contrast to the current investigation, which used self-report information to quantify PA. This is a limitation of the current investigation. Self-report information may be less sensitive than objective PA assessment in discerning relationships between PA and such component elements. Moreover, although self-report measurements of PA cannot readily be compared with one another because of inherent variations in capturing the myriad dimensions of PA, they are often modestly correlated with data obtained from accelerometry. 18 Consideration must also be given to the different PA intensities used in this study than in others. The scope of the analyses was limited to an examination of self-reported levels of MVPA that constitute the current national PA recommendations for obtaining optimal health outcomes, 23 and it is difficult to make comparisons between the current study and others that failed to report PA intensity or used light-intensity PA. Another explanation for the underlying discrepancies may be because of the different populations under investigation. The target population of the current study consisted only of individuals considered to be mobility limited. To meet this criterion, a participant had to score less than 10 on the SPPB.
The study was also interested in identifying select sociodemographic, psychosocial, and health-related variables that could be associated with performance on the SPPB. In support of earlier reports, it was found that age, depressive symptoms, and number of medications were independent correlates of the SPPB score. [8] [9] [10] 24, 25 Contrary to other findings, sex and BMI were not associated with SPPB score. 3, 6, 7 This may be because of the truncated sample, in terms of mobility impairment level, which would make it more difficult to discern such relationships.
Another focus of this investigation was to determine whether participation in MVPA was significantly associated with performance on the 400-m walk test. In addition to being highly predictive of mobility disability risk 15 and mortality, 12 the 400-m walk test captures a distinct domain of physical function performance with respect to its ability to predict other health-related outcomes such as cardiovascular disease. 12 It was found that minutes of MVPA was significantly associated with 400-m walk time. Relevant studies examining the association between MVPA and 400-m walk performance are limited, although in addition to indicating the association between lifestyle PA and SPPB performance described previously, data from the Health ABC Study indicate a linear trend in 400-m walk times in older adults defined as inactive, lifestyle active (light-intensity PA), and exercisers (MVPA). Exercisers had the fastest 400-m walk times, followed by lifestyle-active and then inactive participants. 3 Several possible covariates of 400-m walk performance (age, sex, BMI, number of medications, and depressive symptoms) were also evaluated. Investigators have previously examined and substantiated the relationships between age, sex, BMI, and number of medications and performance on the 400-m walk test. 10, [26] [27] [28] [29] Of the variables considered, only depressive symptoms did not predict 400-m walk time, which may be the result of the truncated sample, which included adults with a specific level of mobility impairment.
Further elucidation of the predictive role of MVPA in performance on the SPPB and 400-m walk test is required. These data are limited because of the cross-sectional nature of the investigation (preventing causal inferences) and the fact that the inclusion and exclusion criteria used for entry into the LIFE-P trial restricted the range of variables. Nevertheless, this study provides evidence that there is an association between SPPB scores and 400-m walk time and minutes of MVPA in an older, vulnerable population. Although MVPA accounted for only a small fraction of the variance in the SPPB and 400-m walk test, it is a modifiable variable and, as such, holds great public health significance. There is a lack of Phase III trial evidence demonstrating that PA interventions can improve physical function and prevent disability. Results from a large study such as the proposed Phase III LIFE trial will enable examination of different levels of dose of PA and changes in function and disability. Author Contributions: ACR: analysis and interpretation of data, preparation of manuscript. JMG, ACK, and SNB: concept and design, acquisition of subjects and data, analysis and interpretation of data, review and editing of manuscript. MPW, MEM, and RAF: concept and design, analysis and interpretation of data, review and editing of manuscript. WJR, JAK, and NWG: acquisition of subjects and data, analysis and interpretation of data, review and editing of manuscript.
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